Literature DB >> 8946185

Benchmark analysis on diabetics at high risk for lower extremity amputation.

M S Pinzur1, R Stuck, R Sage, L Pocius, B Trout, B Wolf, L Vrbos.   

Abstract

After the 1990 establishment of a multidisciplinary foot salvage clinic, 1346 diabetic patients, at high risk for the development of foot ulcers and eventual lower limb amputation, were followed for 4 years. Of the 224 high-risk patients admitted to the hospital, 74 amputations (5.5%) of all or part of a lower limb were performed. Patients undergoing amputation were younger, more severely ill, and required more frequent hospitalizations because of greater organ system involvement. They were also more likely to be institutionalized after discharge. Overall, patients with long-standing adult-onset diabetes, identified as at high risk for foot ulcer development, have a substantially increased risk for lower limb amputation, multiple organ system failure, hospitalization, and institutionalization than do diabetic patients as a whole. Clinical benchmarking facilitates the identification and reduction of unnecessary variations in patient care practices. Here, a formal benchmark analysis provides the current outcome expectations for amputation rates and co-morbidities in patients with diabetes who are classified as at high risk for lower extremity amputation. Management of these patients in a structured, multidisciplinary foot salvage clinic, augmentation of baseline services, and preliminary benchmark data may provide a standard for the measurement of therapeutic interventions that improve patient care.

Entities:  

Mesh:

Year:  1996        PMID: 8946185     DOI: 10.1177/107110079601701109

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  1 in total

1.  Minimally invasive surgery for diabetic plantar foot ulcerations.

Authors:  Fábio Batista; Antonio Augusto Magalhães; Caio Nery; Daniel Baumfeld; Augusto César Monteiro; Fabíola Batista
Journal:  Diabet Foot Ankle       Date:  2011-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.